Pharma group Merck calls £100m international media review

Be the first to comment
Clarityn: media by Publicis
Clarityn: media by Publicis

Merck, the global healthcare company, is set to review its estimated £100 million international media business.

It is understood that the review will focus on international markets excluding the US.

The client has contacted networks ahead of a review.

ZenithOptimedia handles UK media for Clarityn, which was awarded to the agency in 2008 when the brand was owned by Schering-Plough. It also looks after a range of Merck brands in Australia.

Initiative, which shares the US media account with its sister Interpublic agency DraftFCB, also has some of the business in Europe.

Interpublic was awarded the consolidated US business in March 2010, when Merck called a review after its merger with Schering-Plough.

Merck did not return calls when Campaign went to press.

SUBSCRIBE TO CAMPAIGN

Only £49 for 3 months

Includes every print & iPad edition, plus full access to Campaign online and other Brand Republic sites

SUBSCRIBE

Campaign Jobs

Thousands of jobs across advertising, creative, marketing and media

Just published